Covid-19 situation

The effects of the Covid-19 outbreak are escalating daily and is first and foremost a human tragedy, affecting hundreds of thousands of people.
This statement reflects our perspective and the possible impact on our ability to supply as of March 16, 2020. TSS is closely monitoring developments around the novel coronavirus outbreak and we will continue to update you on the situation as it pertains to our business.
At present we have no supply disruption and the company operates without any impact on daily business. We have material in stock to continue to maintain delivery reliability.

Niclas Ohlsson, CEO TSS

We are taking the situation seriously and are focusing our efforts in minimizing the risk on future impact on business operations. We take several actions to support the national and international efforts to even out the spread over time and protect risk groups in the community.  Our contingency plans and activities are centered around the following areas:

Cross-functional response team

  • The management team meet daily to assess the situation and take measures as deemed necessary based on the latest published information.
  • We follow the guidelines of leading global and local governmental, health and work environment authorities.

Protecting employees

  • We currently have no employees known to be affected by the virus.
  • Employees who can perform their work duties from home are encouraged to do so.
  • Meetings are primarily held as video conference, travel is restricted.
  • New safety measurements by anyone receiving goods from external sources.
  • TSS premises have been equipped with additional disinfectant supplies and routines for use, in addition to daily extra cleaning and disinfection.

Supply chain integrity

  • TSS is operating with a structured Supply Chain Risk Management process and are prepared to manage emergency situations as best as possible.
  • We are closely monitoring our supplier’s abilities to supply components for our production. We currently have no delays or component shortage.
  • We demand and review contingency plans from our critical suppliers.
  • We have currently no disruption in delivering to planned destinations.

Stay close to customers

  • We more often than ordinary ask for a forecast update from customer. This is simply to ensure that we will be able to support any fluctuation in supply needs and ensure business continuity.

Financial stability

  • TSS is financially stable, and we currently don’t foresee any major disruption to our business due to the COVID-19 outbreak.

Finally, we are humble to the fact that we are currently part of one of the most important functions in the world. Securing the supply chain of pharmaceuticals, vaccines and other medical supplies and ensuring its integrity is of highest importance in situations like the one we are in now.

Stay safe!

You may also be interested in

Automation is making temperature excursion management simpler and more efficient for clinical sites

Are healthcare professionals working at clinical sites across the world satisfied? It might seem like a strange question to ask, but the way we feel can impact our professional performance in important ways. Perhaps the question is not how satisfied Clinical Operations professionals are, but whether they feel their performance is impacted by lots of time-consuming manual processes that could benefit from automation? Are these processes hampering clinical trial performance?
Read moreDownload Whitepaper

Data-driven supply chains: improving your excursion rate and temperature performance in 5 steps

Data is an essential requirement for improving supply chain processes. But that doesn’t mean that simply collecting more of it will instantly lead to reductions in waste, increases in efficiency and lower excursion rates. Taking a more targeted approach will help you turn supply chain data into insights that can help you understand exactly what is happening at every stage of your pharmaceutical supply chain.
Read moreDownload Whitepaper
A collage illustrating three steps for clinical trials: vaccine vials, data analysis, and a healthcare professional.

3 steps to accelerate Decentralized trials & Release to patients

Seamless monitoring of direct-to-patient shipments within an end-to-end calculation engine enables a digital release in patient's homes. Site centric technology also allows for a decentralized and proactive approach, reducing waste. Furthermore, digitalizing temperature management end-to-end enables a faster release of products for all types of trials and creates a foundation for successful decentralized drives.
Read moreDownload Whitepaper

You may also be interested in

A view of Earth from space at night, representing the global reach of TSS's new BLE technology for temperature monitoring.

On-demand webinar: Introducing BLE technology for temperature monitoring

Get introduced to the solution tailored to GxP critical shipments – BLE technology for temperature monitoring
Read more
A technician assembles a temperature data logger.

TSS Receives CDP SME Climate Score 'SME B' for Strong Climate Actions

TSS, a global company specializing in temperature monitoring for the pharmaceutical supply chain, is proud to announce that it has received an 'SME B' rating from the 2024 CDP SME Climate Score. This recognition highlights TSS’s commitment to being open about its environmental impact and taking steps to reduce it.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.